Hypertension in Saudi Arabia

Saudi Medical Journal

Volumn 28, Issue 1, 2007, Pages 77-84

  Al Nozha, Mansour M ^a,h   Abdullah, Moheeb ^b   Arafah, Mohammed R ^a   Khalil, Mohamed Z ^a   Khan, Nazeer B ^c   Al Mazrou, Yaqoub Y ^d   Al Maatouq, Mohammed A ^a   Al Marzouki, Khalid ^e   Al Khadra, Akram ^f   Nouh, Mohammed S ^a   Al Harthi, Saad S ^a   Al Shahid, Maie S ^g   Al Mobeireek, Abdulellah ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b Prince Sultan Cardiac Centre   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d MINISTRY OF HEALTH   (Saudi Arabia)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^g KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^h TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; EXERCISE; FEMALE; GENDER BIAS; HEALTH PROMOTION; HUMAN; HYPERTENSION; LINEAR SYSTEM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RISK ASSESSMENT; SAUDI ARABIA; SCREENING TEST; SODIUM RESTRICTION; STATISTICAL SIGNIFICANCE; URBAN RURAL DIFFERENCE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SAUDI ARABIA;

EID: 34249808865     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891.
2. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Diagnosis of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413.
3. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162-413.
4. Al-Nozha M, Ali M, Osman A. Arterial Hypertension in Saudi Arabia. Ann Saudi Med 1997; 17: 170-174.
5. Al-Shammari SA, Ali M, Al-Shammari A. Blood lipid concentrations and other cardiovascular risk factors among Saudis. Fam Pract 1994;11: 153-158.
6. Ahmed AF, Mahmoud ME. The prevalence of hypertension in Saudi Arabia. Saudi Med J 1992; 13: 548-551.
7. Mahfouz AA, Al Erian RA. Hypertension in Asir region, south western Saudi Arabia. An epidemiologic study. Southeast Asian J Trop Med Public Health 1993; 24: 284-286.
8. Nazim Uddin K. Prevalence of hypertension in Saudi Arabia. Practitioner East Mediterr Ed 1994; 11: 805-806.
9. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 1001.
10. Statistical Yearbook 40th issue, Kingdom of Saudi Arabia, Ministry of Economic & Planning, Central Department of Statistics 2004 AD: 2-9.
11. Zubaid M, Suresh CG, Thalib L, Rashed W. Differential distribution of risk factors and outcome of acute coronary syndrome in Kuwait: Three years experience. Med Princ Pract 2004; 13: 63-68.
12. Suresh CG, Zubaid M, Thalib L, Rashed W, David T. Racial variation in risk factors and occurrence of acute myocardial infarction: Comparison between Arab and South Asian men in Kuwait. Indian Heart J 2002; 54: 266-270.
13. Jaddou HY, Bateiha AM, Ajlouni KM. Prevalence, awareness and management of hypertension in a recently urbanised community, eastern Jordan. J Hum Hypertens. 2000; 14: 497-501.
14. Jaddou HY, Batiehah AM, Ajlouni KM. Prevalence and associated factors of hypertension: Results from a three community-based survey, Jordan. J Hum Hypertens 1996; 10: 815-821.
15. Shipp ML. Awareness status and prevalence of hypertension in a group of urban Haitians: Findings of a population-based survey. Ethn Dis 2001; 11: 419-430.
16. Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J 2003; 55: 245-251.
17. Jenei Z, Pall D, Katona E, Kakuk G, Polgar P. The epidemiology of hypertension and its associated risk factors in the city of Debrecen, Hungary. Public Health 2002; 116: 138-144.
18. Bener A, Al-Suwaidi J, Al-Jaber K, Al-Marri S, Dagash MH, Elbagi IE. The prevalence of hypertension and its associated risk factors in a newly developed country. Saudi Med J 2004; 25: 918-922.
19. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217-223.
20. Ibrahim M, Rizk H, Appel L, Aroussy W, Helmy S, Sharaf Y, et al. Hypertension prevalence, awareness, treatment and control in Egypt: results from the Egyptian National Hypertension Project (NHP). Hypertension 1995; 26: 886-890.
21. Dongfeng Gu, Kristi Reynolds, Xigui Wu, Jing Chen, Xiufang Duan, Paul Muntner. Prevalence, Awareness, Treatment, and Control of Hypertension in China. Hypertension 2004; 26: 886-890.
22. Pickering T. New Guidelines on Diet and Blood Pressure. Hypertension 2006; 47: 135-136.
23. Anderson C., Appel L. Dietary Modification and CVD Prevention: A Matter of Fat. JAMA 2006; 295: 693-695.
24. Writing Group of the PREMIER Collaborative Research Group. Effects of Comprehensive Lifestyle Modification on Blood Pressure Control Main Results of the PREMIER Clinical Trial. JAMA 2003; 289: 2083-2093.
25. MacGregor GA. Salt and hypertension. Br J Clin Pharmacol 1986; Suppl 2: 123S-128S.
26. Skrabal F, Aubock J, Hortnagl H. Low sodium/high potassium diet for prevention of hypertension: Probable mechanisms of action. Lancet 1981; 2: 895-900.
27. MacGregor GA. Sodium is more important than calcium in essential hypertension. Hypertension 1985; 7: 628-640.
28. He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA. Plasma sodium: Ignored and underestimated. Hypertension 2005; 45: 98-102.
29. Cakir H, Pinar R. Randomized Controlled Trial on Lifestyle Modification in Hypertensive Patients. Western Journal of Nursing Research 2006; 28: 190-209.
30. Fodor JG, Whitmore B, Leenen F, Larochelle P. Lifestyle modifications to prevent and control hypertension. CMAJ 1999; 160 (9 Suppl): S29-34.
31. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med 2001; 344: 3-10.
32. Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK, et al. Racial differences in blood pressure control: Potential explanatory factors. Am J Med 2006; 119: 70. e9-15.
33. Hajjar I, Kotchen T. Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
34. Trenkwalder P, Ruland D, Stender M, Gebhard J, Trenkwalder C, Lydtin H, et al. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: Results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens 1994; 12: 709-716.
35. Asai Y, Ishikawa S, Kayaba K, Goto T, Nago N, Kario K, et al. Prevalence, awareness, treatment, and control of hypertension in Japanese rural communities. Nippon Koshu Eisei Zasshi 2001; 48: 827-836. [abstract].
36. Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, Petrzilkova Z, et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens 2004; 22: 1479-1485.
37. Gu DF, Jiang H, Wu XG, Reynolds K, Gan WQ, Liu DH, et al. Prevalence, awareness, treatment and control of hypertension in Chinese adults. Zhonghua Yu Fang Yi Xue Za Zhi 2003; 37: 84-89. [abstract]
38. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: The Ansan study. J Hypertens 2001; 19: 1523-1532.
39. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal: The PAP study. J Hypertens 2005; 23: 1661-1666.
40. Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B; Cooperative Research Group of the Study on Trends of Cardiovascular Diseases in China and Preventive Strategy for the 21st Century. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 2004; 27: 703-709.
41. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, Graciani A, Luque M, de la Cruz-Troca JJ, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002; 20: 2157-2164.